Next Article in Journal
RETRACTED: Asfour et al. Amitriptyline-Based Biodegradable PEG-PLGA Self-Assembled Nanoparticles Accelerate Cutaneous Wound Healing in Diabetic Rats. Pharmaceutics 2022, 14, 1792
Previous Article in Journal
Ionic Liquids in Pharmaceutical and Biomedical Applications: A Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Alhakamy et al. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021, 13, 977

by
Nabil A. Alhakamy
1,2,3,
Mohammed W. Al-Rabia
4,
Shadab Md
1,2,3,
Alaa Sirwi
5,
Selwan Saud Khayat
1,
Sahar Saad AlOtaibi
1,
Raghad Abkar Hakami
1,
Hadeel Al Sadoun
6,
Basmah Medhat Eldakhakhny
7,
Wesam H. Abdulaal
8,
Hibah M. Aldawsari
1,3,
Shaimaa M. Badr-Eldin
1,9,* and
Mahmoud A. Elfaky
5
1
Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Advanced Drug Delivery Research Group, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
3
Center of Excellence for Drug Research and Pharmaceutical Industries, King Abdulaziz University, Jeddah 21589, Saudi Arabia
4
Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
5
Department of Natural Products and Alternative, Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia
6
Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
7
Department of Clinical Biochemistry, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
8
Department of Biochemistry, Faculty of Science, Cancer and Mutagenesis Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia
9
Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo 11562, Egypt
*
Author to whom correspondence should be addressed.
Pharmaceutics 2024, 16(1), 150; https://doi.org/10.3390/pharmaceutics16010150
Submission received: 10 January 2024 / Accepted: 16 January 2024 / Published: 22 January 2024
The journal retracts the article, “Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans” [1] cited above.
Following publication, concerns were brought to the attention of the publisher regarding the duplication of images.
Adhering to our complaint’s procedure, an investigation was conducted, which confirmed the duplication of Figure 3 in [1] with Figure 2B of [2].
While the authors fully cooperated with the Editorial Office during the investigation, they were unable to satisfactorily explain the overlap of figures and meet the required quality standards of raw images in order to consider a correction as per the journals original image requirements policy (https://www.mdpi.com/journal/pharmaceutics/instruc-tions#oriimages). As a result, the Editorial Board and Editor-in-Chief were unable to confirm the reliability of the findings and subsequently decided to retract this paper.
This retraction was approved by the Editor-in-Chief of the journal Pharmaceutics.
The authors did not agree to this retraction.

References

  1. Alhakamy, N.A.; Al-Rabia, M.W.; Md, S.; Sirwi, A.; Khayat, S.S.; AlOtaibi, S.S.; Hakami, R.A.; Al Sadoun, H.; Eldakhakhny, B.M.; Abdulaal, W.H.; et al. RETRACTED: Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021, 13, 977. [Google Scholar] [CrossRef] [PubMed]
  2. Alhakamy, N.A.; Ahmed, O.A.A.; Fahmy, U.A.; Md, S. Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic Cancer. Pharmaceuticals 2021, 14, 729. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Alhakamy, N.A.; Al-Rabia, M.W.; Md, S.; Sirwi, A.; Khayat, S.S.; AlOtaibi, S.S.; Hakami, R.A.; Al Sadoun, H.; Eldakhakhny, B.M.; Abdulaal, W.H.; et al. RETRACTED: Alhakamy et al. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021, 13, 977. Pharmaceutics 2024, 16, 150. https://doi.org/10.3390/pharmaceutics16010150

AMA Style

Alhakamy NA, Al-Rabia MW, Md S, Sirwi A, Khayat SS, AlOtaibi SS, Hakami RA, Al Sadoun H, Eldakhakhny BM, Abdulaal WH, et al. RETRACTED: Alhakamy et al. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021, 13, 977. Pharmaceutics. 2024; 16(1):150. https://doi.org/10.3390/pharmaceutics16010150

Chicago/Turabian Style

Alhakamy, Nabil A., Mohammed W. Al-Rabia, Shadab Md, Alaa Sirwi, Selwan Saud Khayat, Sahar Saad AlOtaibi, Raghad Abkar Hakami, Hadeel Al Sadoun, Basmah Medhat Eldakhakhny, Wesam H. Abdulaal, and et al. 2024. "RETRACTED: Alhakamy et al. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021, 13, 977" Pharmaceutics 16, no. 1: 150. https://doi.org/10.3390/pharmaceutics16010150

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop